TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/9/23 16:26 | 6/7/23 | ADVM | Adverum Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Rubinstein Linda M | CA | O | CFO | P | 145 | 1.45 | 0 | 100 | New | 100 | D | ||||||||||||||
12/18/06 16:01 | 12/14/06 | SLXA | Solexa, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Rubinstein Linda M | CA | O | VP,CFO | M.dm | 136 | 7.41 | 0 | 18 | 0 | D | |||||||||||||||
12/18/06 16:01 | 12/14/06 | SLXA | Solexa, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Rubinstein Linda M | CA | O | VP,CFO | S.dm | -233 | 12.71 | 0 | -18 | -100 | 0 | D | ||||||||||||||
12/15/06 14:00 | 12/13/06 | SLXA | Solexa, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Rubinstein Linda M | CA | O | VP,CFO | M.d | 451 | 6.29 | 0 | 72 | 0 | D | |||||||||||||||
12/15/06 14:00 | 12/13/06 | SLXA | Solexa, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Rubinstein Linda M | CA | O | VP,CFO | S.d | -908 | 12.66 | 0 | -72 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |